René Rizzoli

TL;DR: In this paper, the European Foundation for Osteoporosis and Bone disease (subsequently the International osteopo- rosis Foundation) published guidelines for the diagnosis and management of osteoporrosis in a European setting.

TL;DR: Treatment of postmenopausal osteoporosis with strontium ranelate leads to early and sustained reductions in the risk of vertebral fractures.

TL;DR: It is indicated that during pubertal development, major differences are observed in bone mass growth according to sex and skeletal site, suggesting that the generally accepted notion that in both males and females bone mass continues to substantially accumulate at all skeletal sites until the fourth decade may not be a constant in human physiology.

TL;DR: The results indicate that in a cohort of healthy females with apparently adequate intakes of energy and calcium, bone mass accumulation is drastically reduced by 16 yr of age in both lumbar spine and femoral neck.

TL;DR: It has been generally accepted that peak bone mass at any skeletal site is attained in both sexes during the mid-thirties, and recent studies indicate that in healthy Caucasian females with apparently adequate intakes of energy and calcium, bone mass accumulation can virtually be completed before the end of the second decade.